Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
This document reports on a Phase 1/2 clinical trial evaluating CyberKnife SBRT followed by Gemcitabine in patients with unresectable or loca…
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial of bevacizumab, erlotinib, and capecitabine in patients with advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy [Phase 2]
Phase 2 multicenter trial evaluating reinforced stapling during distal pancreatectomy, sponsored by Wakayama Medical University; the study s…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy [NA]
A completed clinical trial evaluating Roux-en-Y anastomosis of the pancreatic stump to prevent pancreatic fistula after distal pancreatectom…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating gemcitabine plus radiation therapy for pancreatic cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating the combination of chemotherapy and radiation therapy in patients with pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Maintenance Dovitinib for Colorectal and Pancreas Cancer [Phase 2]
This Phase 2 maintenance study of dovitinib in colorectal cancer and pancreatic cancer was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine plus oxaliplatin in refractory locally advanced or metastatic pancreatic cancer has completed and repor…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas [Phase 2]
This is a Phase 2 clinical trial update evaluating gemcitabine alone or in combination with other chemotherapy drugs for metastatic pancreat…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy plus radiation therapy in patients with advanced pancreatic cancer has complete…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach [Phase 1]
This Phase 1 trial evaluated the combination of radiation therapy and chemotherapy in patients with pancreatic cancer or gastric cancer; the…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects [Phase 1]
Phase 1 trial assessing multiple doses of Vitamin E δ-Tocotrienol in healthy subjects has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas [Phase 2]
Phase 2 trial update of Gemcitabine plus ISIS 2503 in advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 trial evaluating nab-paclitaxel in combination with gemcitabine in fragile patients with a…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of irreversible electroporation for refractory tumors in the liver…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
A terminated clinical trial update investigating whether baseline CT perfusion parameters can prognosticate outcomes for pancreatic cancer p…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
This ClinicalTrials.gov entry reports a completed study evaluating the relationship between vitamin D biomarkers and survival in blood sampl…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine, docetaxel, and capecitabine as adjuvant therapy for pancreatic cancer has completed enrollment with re…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) [Phase 2]
A Phase 2 trial assessing the GTX combination of gemcitabine, docetaxel, and capecitabine in metastatic pancreatic cancer has completed and …
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar [Phase 2]
A Phase 2 study in inoperable non-metastatic pancreatic cancer (Stage IVA) evaluated neoadjuvant GTX with radiation and gemcitabine (Gemzar)…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Plastic vs. Covered Metal vs. Uncovered Metal Biliary Stents for the Management of Malignant Biliary Obstruction [NA]
A completed clinical trial comparing plastic, covered metal, and uncovered metal biliary stents for malignant biliary obstruction in pancrea…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating the combination of irinotecan, oxaliplatin, and cetuximab in locally advanced or metastatic pancreatic cancer has…
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions [NA]
A clinical trial comparing Modified Wet Suction Technique versus Dry Suction Technique for EUS-FNA of solid lesions; the study status is cur…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen [Phase 3]
Phase 3 trial comparing Larotaxel with continuous 5-FU in advanced pancreatic cancer previously treated with gemcitabine; trial status compl…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 2]
An update on a Phase 2 trial evaluating gemcitabine hydrochloride for pancreatic cancer that has been surgically removed, with the study sta…